trending Market Intelligence /marketintelligence/en/news-insights/trending/posdr7ev8a602a125jczuq2 content esgSubNav
In This List

United Laboratories director retires

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


United Laboratories director retires

Huang Bao Gang has retired as independent nonexecutive director of The United Laboratories International Holdings Ltd. due to age and personal health issues.

The company said Gang has confirmed that he has no disagreement with the board and there is no matter that needs to be brought to the attention of the company's shareholders.

Hong Kong-based United Laboratories International is an investment holding company, which manufactures and sells pharmaceutical products.